Neurobiology of Disease,
Journal Year:
2023,
Volume and Issue:
177, P. 105986 - 105986
Published: Jan. 2, 2023
Recent
human
and
animal
model
experimental
studies
revealed
novel
pathways
for
fluid
movement,
immune
cell
trafficking
metabolic
waste
clearance
in
CNS.
These
raise
the
intriguing
possibility
that
newly
discovered
pathways,
including
glymphatic
system,
lymphatic
meningeal
vessels
skull-brain
communication
channels,
are
impaired
aging
neurovascular
neurodegenerative
diseases
associated
with
dementia,
Alzheimer's
disease
(AD)
AD-related
dementia.
We
provide
an
overview
of
dural
systems,
review
current
methods
approaches
used
to
study
flow
humans
animals,
discuss
evidence
controversies
related
its
role
CNS
homeostasis
under
physiological
pathophysiological
conditions.
Non-invasive
imaging
needed
fully
understand
mechanisms
driving
movement
their
roles
across
lifespan
healthy
aging-related
Molecular Neurodegeneration,
Journal Year:
2020,
Volume and Issue:
15(1)
Published: July 16, 2020
Abstract
Alzheimer’s
disease
(AD)
is
the
most
common
neurodegenerative
disorder
seen
in
age-dependent
dementia.
There
currently
no
effective
treatment
for
AD,
which
may
be
attributed
part
to
lack
of
a
clear
underlying
mechanism.
Studies
within
last
few
decades
provide
growing
evidence
central
role
amyloid
β
(Aβ)
and
tau,
as
well
glial
contributions
various
molecular
cellular
pathways
AD
pathogenesis.
Herein,
we
review
recent
progress
with
respect
Aβ-
tau-associated
mechanisms,
discuss
dysfunction
emphasis
on
neuronal
receptors
that
mediate
Aβ-induced
toxicity.
We
also
other
critical
factors
affect
pathogenesis,
including
genetics,
aging,
variables
related
environment,
lifestyle
habits,
describe
potential
apolipoprotein
E
(APOE),
viral
bacterial
infection,
sleep,
microbiota.
Although
have
gained
much
towards
understanding
aspects
this
devastating
disorder,
greater
commitment
research
mechanism,
diagnostics
will
needed
future
research.
Brain,
Journal Year:
2021,
Volume and Issue:
145(8), P. 2785 - 2795
Published: Dec. 13, 2021
Recent
evidence
has
shown
the
existence
of
a
CNS
'waste
clearance'
system,
defined
as
glymphatic
system.
Glymphatic
abnormalities
have
been
described
in
several
neurodegenerative
conditions,
including
Alzheimer's
and
Parkinson's
disease.
function
not
thoroughly
explored
multiple
sclerosis,
where
processes
are
intermingled
with
inflammatory
processes.
We
aimed
to
investigate
system
sclerosis
evaluate
its
association
clinical
disability,
disease
course,
demyelination
neurodegeneration,
quantified
using
different
MRI
techniques.
In
this
retrospective
study,
we
enrolled
71
patients
(49
relapsing-remitting
22
progressive
sclerosis)
32
age-
sex-matched
healthy
control
subjects.
All
subjects
underwent
neurological
assessment
high-resolution
T1,
T2
double
inversion
recovery
sequences,
diffusion
susceptibility
weighted
imaging.
calculated
along
perivascular
space
index,
proxy
for
function,
cortical
deep
grey
matter
volume,
white
lesion
volume
normal-appearing
microstructural
damage.
Multiple
showed
an
overall
lower
index
versus
controls
(estimated
mean
difference:
-0.09,
P
=
0.01).
Both
had
-0.06,
0.04
-0.19,
0.001
patients).
Progressive
0.03).
patients,
was
associated
more
severe
disability
(r
-0.45,
0.001)
longer
duration
-0.37,
0.002).
Interestingly,
detected
negative
between
first
4.13
years
course
-0.38,
0.04)
without
any
thereafter
(up
34
duration).
Lower
higher
-0.36,
0.003)
-0.41,
0.30,
0.007)
0.42,
atrophy,
reduced
fractional
anisotropy
increased
diffusivity
matter.
Our
results
suggest
that
is
impaired
especially
stages.
Impaired
measures
both
neurodegeneration
reflects
disability.
These
findings
impairment
may
be
pathological
mechanism
underpinning
sclerosis.
The
dynamic
interplay
other
substrates
deserves
further
investigation.
NeuroImage Clinical,
Journal Year:
2021,
Volume and Issue:
33, P. 102926 - 102926
Published: Dec. 27, 2021
Recent
studies
have
shown
that
choroid
plexuses
(CP)
may
be
involved
in
the
neuro-immune
axes,
playing
a
role
interaction
between
central
and
peripheral
inflammation.
Here
we
aimed
to
investigate
CP
volume
alterations
depression
their
associations
with
inflammation.51
depressed
participants
(HDRS
score
>
13)
25
age-
sex-matched
healthy
controls
(HCs)
from
Wellcome
Trust
NIMA
consortium
were
re-analysed
for
study.
All
underwent
full
cytokine
profiling
simultaneous
[11C]PK11195
PET/structural
MRI
imaging
measuring
neuroinflammation
respectively.We
found
significantly
greater
subjects
compared
HCs
(t(76)
=
+2.17)
was
positively
correlated
PET
binding
anterior
cingulate
cortex
(r
0.28,
p
0.02),
prefrontal
0.24,
0.04),
insular
but
not
inflammatory
markers:
CRP
levels
0.07,
0.53),
IL-6
-0.08,
0.61),
TNF-α
-0.06,
0.70).
The
0.34,
0.005).
Integration
of
transcriptomic
data
Allen
Human
Brain
Atlas
brain
map
depicting
correlations
significant
gene
enrichment
several
pathways
neuroinflammatory
response.This
result
supports
hypothesis
changes
barriers
cause
reduction
solute
exchanges
blood
CSF,
disturbing
homeostasis
ultimately
contributing
inflammation
depression.
Given
anomalies
been
recently
detected
other
disorders,
these
results
specific
might
extend
conditions
component.
Fluids and Barriers of the CNS,
Journal Year:
2022,
Volume and Issue:
19(1)
Published: March 14, 2022
Abstract
Background
In
sporadic
Alzheimer’s
disease
(AD),
brain
amyloid-beta
(Aβ)
deposition
is
believed
to
be
a
consequence
of
impaired
Aβ
clearance,
but
this
relationship
not
well
established
in
living
humans.
CSF
major
feature
glymphatic
clearance
(BGC),
has
been
shown
abnormal
AD
murine
models.
MRI
phase
contrast
and
intrathecally
delivered
studies
have
reported
reduced
flow
AD.
Using
PET
tau
tracer
18
F-THK5117,
we
previously
that
the
ventricular
was
associated
with
elevated
levels.
Methods
present
study,
use
two
tracers,
F-THK5351
11
C-PiB
estimate
calculated
from
early
dynamic
frames
9
normal
controls
15
participants.
Results
observed
measures
were
correlated
(r
=
0.66,
p
<
0.01),
reductions
27%,
respectively.
We
also
replicated
significant
between
(
F-THK5351)
load
−
0.64,
n
24,
0.01).
With
larger
sample
size,
extended
our
observations
show
cortical
thickness
cognitive
performance.
Conclusions
Overall,
findings
support
hypothesis
failed
related
pathology
Longitudinal
are
needed
determine
whether
predictor
progressive
amyloidosis
or
its
consequence.
Aging and Disease,
Journal Year:
2022,
Volume and Issue:
unknown, P. 0 - 0
Published: Jan. 1, 2022
Ependymal
cells
are
indispensable
components
of
the
central
nervous
system
(CNS).
They
originate
from
neuroepithelial
neural
plate
and
show
heterogeneity,
with
at
least
three
types
that
localized
in
different
locations
CNS.
As
glial
CNS,
accumulating
evidence
demonstrates
ependymal
play
key
roles
mammalian
CNS
development
normal
physiological
processes
by
controlling
production
flow
cerebrospinal
fluid
(CSF),
brain
metabolism,
waste
clearance.
have
been
attached
to
great
importance
neuroscientists
because
their
potential
participate
disease
progression.
Recent
studies
demonstrated
progression
various
neurological
diseases,
such
as
spinal
cord
injury
hydrocephalus,
raising
possibility
they
may
serve
a
therapeutic
target
for
disease.
This
review
focuses
on
function
developmental
well
after
discusses
underlying
mechanisms
functions
cells.
Brain Behavior and Immunity,
Journal Year:
2023,
Volume and Issue:
111, P. 202 - 210
Published: April 17, 2023
Current
research
into
mood
disorders
indicates
that
circulating
immune
mediators
participating
in
the
pathophysiology
of
chronic
somatic
have
potent
influences
on
brain
function.
This
paradigm
has
brought
to
fore
use
anti-inflammatory
therapies
as
adjunctive
standard
antidepressant
therapy
improve
treatment
efficacy,
particularly
subjects
do
not
respond
medication.
Such
new
practice
requires
biomarkers
tailor
these
those
most
likely
benefit
but
also
validated
mechanisms
action
describing
interaction
between
peripheral
immunity
and
function
optimize
target
intervention.
These
are
generally
studied
preclinical
models
try
recapitulate
human
disease,
MDD,
through
peripherally
induced
sickness
behaviour.
In
this
proposal
paper,
after
an
appraisal
data
rodent
their
adherence
clinical
cohorts,
we
put
forward
a
modified
model
periphery-brain
interactions
goes
beyond
currently
established
view
microglia
cells
drivers
depression.
Instead,
suggest
that,
for
patients
with
mild
levels
inflammation,
barriers
primary
actors
disease
resistance.
We
then
highlight
gaps
novel
lines
research.
Brain Communications,
Journal Year:
2023,
Volume and Issue:
5(3)
Published: Jan. 1, 2023
Abstract
The
glymphatic
system
is
a
perivascular
fluid
clearance
system,
most
active
during
sleep,
considered
important
for
clearing
the
brain
of
waste
products
and
toxins.
Glymphatic
failure
hypothesized
to
underlie
protein
deposition
in
neurodegenerative
disorders
like
Alzheimer’s
disease.
Preclinical
evidence
suggests
that
functioning
also
essential
recovery
from
traumatic
injury,
which
involves
release
debris
toxic
proteins
need
be
cleared
brain.
In
cross-sectional
observational
study,
we
estimated
using
diffusion
tensor
imaging
along
spaces,
an
MRI-derived
measure
water
diffusivity
surrounding
veins
periventricular
region,
13
non-injured
controls
37
subjects
who
had
experienced
injury
∼5
months
previously.
We
additionally
measured
volume
space
T2-weighted
MRI.
plasma
concentrations
neurofilament
light
chain,
biomarker
severity,
subset
subjects.
Diffusion
spaces
index
was
modestly
though
significantly
lower
with
compared
when
covarying
age.
significantly,
negatively
correlated
blood
levels
chain.
Perivascular
did
not
differ
as
correlate
suggesting
it
may
less
sensitive
injury-related
changes.
impairment
after
could
due
mechanisms
such
mislocalization
channels,
inflammation,
proteinopathy
and/or
sleep
disruption.
promising
method
estimating
clearance,
additional
work
needed
confirm
results
assess
associations
outcome.
Understanding
changes
following
inform
novel
therapies
improve
short-term
reduce
later
risk
neurodegeneration.
Annals of Neurology,
Journal Year:
2024,
Volume and Issue:
95(6), P. 1080 - 1092
Published: March 13, 2024
Objective
The
aim
of
this
study
was
to
investigate
whether,
compared
pediatric
healthy
controls
(HCs),
the
glymphatic
system
is
impaired
in
multiple
sclerosis
(MS)
patients
according
their
cognitive
status,
and
assess
its
association
with
clinical
disability
MRI
measures
brain
structural
damage.
Method
s
Sixty‐five
MS
(females
=
62%;
median
age
15.5
[interquartile
range,
IQR
14.5;17.0]
years)
23
age‐
sex‐matched
HCs
44%;
14.1
[IQR
11.8;16.2]
underwent
neurological,
neuropsychological
3.0
Tesla
assessment,
including
conventional
diffusion
tensor
imaging
(DTI).
We
calculated
along
perivascular
space
(DTI‐ALPS)
index,
a
proxy
function.
Cognitive
impairment
(Co‐I)
defined
as
at
least
2
domains.
Results
No
significant
differences
DTI‐ALPS
index
were
found
between
cognitively
preserved
(Co‐P)
(estimated
mean
difference
[EMD]
−0.002
[95%
confidence
interval
−0.069;
0.065],
FDR‐p
0.956).
Compared
Co‐P
patients,
Co‐I
(n
20)
showed
significantly
lower
(EMD
−0.136
−0.214;
−0.058],
≤
0.004).
In
HCs,
no
associations
observed
normalized
brain,
cortical
thalamic
volumes,
normal‐appearing
white
matter
(NAWM)
fractional
anisotropy
(FA)
diffusivity
(MD)
(FDR‐p
≥
0.348).
higher
WM
lesion
volume
(LV),
NAWM
MD,
volume,
FA
associated
0.016).
Random
Forest
selected
(relative
importance
[RI]
100%),
LV
(RI
59.5%)
MD
57.1%)
intelligence
quotient
51.3%)
informative
predictors
(out‐of‐bag
area
under
curve
0.762).
Interpretation
Glymphatic
dysfunction
occurs
MS,
focal
lesions,
irreversible
tissue
loss
accumulation
impairment.
ANN
NEUROL
2024;95:1080–1092